<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1491669</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2024.1491669</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Bioengineering and Biotechnology</subject>
<subj-group>
<subject>Mini Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Perspective of 3D culture in medicine: transforming disease research and therapeutic applications</article-title>
<alt-title alt-title-type="left-running-head">Park et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2024.1491669">10.3389/fbioe.2024.1491669</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Park</surname>
<given-names>Chan Hum</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/861751/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Park</surname>
<given-names>Jung Ho</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Suh</surname>
<given-names>Yong Joon</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Nano-Bio Regenerative Medical Institute</institution>, <institution>College of Medicine</institution>, <institution>Hallym University</institution>, <addr-line>Chuncheon</addr-line>, <country>Republic of Korea</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Departments of Otorhinolaryngology-Head and Neck Surgery</institution>, <institution>Chuncheon Sacred Heart Hospital</institution>, <institution>School of Medicine</institution>, <institution>Hallym University</institution>, <addr-line>Chuncheon</addr-line>, <country>Republic of Korea</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Breast and Endocrine Surgery</institution>, <institution>Hallym University Sacred Heart Hospital</institution>, <addr-line>Anyang</addr-line>, <country>Republic of Korea</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/170461/overview">Mona Kamal Marei</ext-link>, Alexandria University, Egypt</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1210802/overview">Chen Yu Huang</ext-link>, National Cheng Kung University, Taiwan</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Yong Joon Suh, <email>nicizm@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>19</day>
<month>12</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>12</volume>
<elocation-id>1491669</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>09</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>12</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Park, Park and Suh.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Park, Park and Suh</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>3D cell culture is gaining momentum in medicine due to its ability to mimic real tissues (<italic>in vivo</italic>) and provide more accurate biological data compared to traditional methods. This review explores the current state of 3D cell culture in medicine and discusses future directions, including the need for standardization and simpler protocols to facilitate wider use in research.</p>
<sec>
<title>Purpose</title>
<p>3D cell culture develops life sciences by mimicking the natural cellular environment. Cells in 3D cultures grow in three dimensions and interact with a matrix, fostering realistic cell behavior and interactions. This enhanced model offers significant advantages for diverse research areas.</p>
</sec>
<sec>
<title>Methods</title>
<p>By mimicking the cellular organization and functionalities found in human tissues, 3D cultures provide superior platforms for studying complex diseases like cancer and neurodegenerative disorders. This enables researchers to gain deeper insights into disease progression and identify promising therapeutic targets with greater accuracy. 3D cultures also play a crucial role in drug discovery by allowing researchers to effectively assess potential drugs&#x2019; safety and efficacy.</p>
</sec>
<sec>
<title>Results</title>
<p>3D cell culture&#x2019;s impact goes beyond disease research. It holds promise for tissue engineering. By replicating the natural tissue environment and providing a scaffold for cell growth, 3D cultures pave the way for regenerating damaged tissues, offering hope for treating burns, organ failure, and musculoskeletal injuries. Additionally, 3D cultures contribute to personalized medicine. Researchers can use patient-derived cells to create personalized disease models and identify the most effective treatment for each individual.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>With ongoing advancements in cell imaging techniques, the development of novel biocompatible scaffolds and bioreactor systems, and a deeper understanding of cellular behavior within 3D environments, 3D cell culture technology stands poised to revolutionize various aspects of healthcare and scientific discovery.</p>
</sec>
</abstract>
<kwd-group>
<kwd>3D culture</kwd>
<kwd>stem cell</kwd>
<kwd>scaffold</kwd>
<kwd>biomaterial</kwd>
<kwd>bioprinting</kwd>
<kwd>medicine</kwd>
</kwd-group>
<contract-sponsor id="cn001">Korea Health Industry Development Institute<named-content content-type="fundref-id">10.13039/501100003710</named-content>
</contract-sponsor>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Tissue Engineering and Regenerative Medicine</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Three-dimensional (3D) cell culture models aim to recreate natural environments outside the body, allowing cells to grow and interact in three dimensions (<xref ref-type="bibr" rid="B43">Haycock, 2011</xref>; <xref ref-type="bibr" rid="B64">Ravi et al., 2015</xref>; <xref ref-type="bibr" rid="B40">Gu et al., 2020</xref>; <xref ref-type="bibr" rid="B84">Yoon, 2023</xref>). By culturing various cell types within a 3D extracellular matrix, nutrients, oxygen, and drugs can efficiently reach cells, closely mimicking physiological conditions (<xref ref-type="bibr" rid="B50">Lee et al., 2019</xref>). Traditional two-dimensional (2D) cell culture systems, while convenient and cost-effective, lack the ability to accurately replicate the complex architecture and microenvironment found in living tissues (<xref ref-type="bibr" rid="B23">Duval et al., 2017</xref>). This limitation can lead to misleading results, particularly regarding the response of cancer cells to anticancer agents, as 2D cultures fail to mimic the true 3D tumor microenvironment (<xref ref-type="bibr" rid="B34">Gao et al., 2017</xref>; <xref ref-type="bibr" rid="B12">Brancato et al., 2020</xref>).</p>
<p>The emergence of 3D cell culture systems presents promising solutions to bridge the gap between laboratory cell cultures and <italic>in vivo</italic> conditions (<xref ref-type="bibr" rid="B2">Alghuwainem et al., 2019</xref>; <xref ref-type="bibr" rid="B21">Diaz-Rodriguez et al., 2019</xref>; <xref ref-type="bibr" rid="B59">Mofazzal Jahromi et al., 2019</xref>; <xref ref-type="bibr" rid="B53">Lin et al., 2020</xref>; <xref ref-type="bibr" rid="B74">Terrell et al., 2020</xref>). These systems offer higher physiological relevance, closely resembling cell behavior within the body, and provide new avenues for cell-based research and clinical trials (<xref ref-type="bibr" rid="B78">van Duinen et al., 2015</xref>; <xref ref-type="bibr" rid="B10">Bertucci et al., 2019</xref>; <xref ref-type="bibr" rid="B13">Calejo et al., 2019</xref>; <xref ref-type="bibr" rid="B42">Ham et al., 2019</xref>; <xref ref-type="bibr" rid="B75">Thelu et al., 2020</xref>). The intricacy inherent in 3D systems presents multifaceted challenges, notably in the selection of scaffold materials and cell types (<xref ref-type="bibr" rid="B4">Ashok et al., 2020</xref>). Researchers are confronted with the delicate decision between natural and synthetic scaffold materials, as well as the nuanced choice between utilizing autologous or adult-derived stem cells. Moreover, the meticulous fabrication of nanoscale scaffolds or the creation of microscale structures with precise architectures to support cell growth requires meticulous deliberation.</p>
<p>The dynamic nature of 3D cultures, moreover, introduces complexities in maintaining optimal culture environments over prolonged periods (<xref ref-type="bibr" rid="B28">Fernandes et al., 2020</xref>). Unlike static 2D cultures, 3D systems demand sophisticated strategies to facilitate nutrient diffusion, oxygenation, and waste removal throughout the entire structure. Innovations such as perfusion bioreactors and microfluidic systems have been devised to tackle these challenges, offering enhanced control over culture conditions, and ensuring the sustained viability of 3D constructs.</p>
<p>The integration of diverse cell types within 3D culture systems introduces yet another layer of intricacy (<xref ref-type="bibr" rid="B66">Ryu et al., 2019</xref>). Replicating the heterogeneous composition of tissues and organs <italic>in vivo</italic> often necessitates the co-cultivation of disparate cell populations to accurately simulate physiological interactions. This interdisciplinary endeavor mandates seamless collaboration among cell biologists, materials scientists, engineers, and clinicians to meticulously design and optimize 3D culture platforms tailored for specific applications, encompassing surgical research and regenerative medicine.</p>
<p>This review explores the current state of 3D culture in medicine and discusses future directions, such as standardization and simpler protocols, to facilitate broader adoption in surgical research. Addressing these challenges will be crucial for realizing the possibilities of 3D cell culture in medical applications and beyond.</p>
<sec id="s1-1">
<title>Environments</title>
<p>Essential cultural platforms in biomedical research have been investigated particularly for drug discovery and anticancer investigations (<xref ref-type="bibr" rid="B48">Kim et al., 2020</xref>). The rising demand for advanced 3D cell culture models has intensified the need for sophisticated 3D cultivation techniques, from laboratory setups to industrial-scale production (<xref ref-type="bibr" rid="B12">Brancato et al., 2020</xref>; <xref ref-type="bibr" rid="B79">Wan et al., 2020</xref>). These bioreactors boast precise control systems, ensuring reproducible spheroid formation, a vital aspect for studying cellular behavior and drug responses. Beyond conventional applications, bioreactors play a crucial role in facilitating dynamic cell interactions and responses (<xref ref-type="bibr" rid="B29">Ferreira et al., 2018</xref>). They offer precise control over environmental conditions, including temperature, pH, and nutrient supply, ensuring optimal cell growth and function (<xref ref-type="fig" rid="F1">Figure 1</xref>). Additionally, advancements in bioreactor design enable the integration of various monitoring and control systems for enhanced functionality.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>The components for 3D cell culture are shown here. ECM, extracellular matrix.</p>
</caption>
<graphic xlink:href="fbioe-12-1491669-g001.tif"/>
</fig>
<p>Utilizing established 3D culture models, researchers have made significant strides in understanding cancer progression mechanisms (<xref ref-type="bibr" rid="B22">Dumont et al., 2019</xref>; <xref ref-type="bibr" rid="B85">Zhang et al., 2020</xref>). These models provide insights into morphological and cellular changes associated with disease progression, offering valuable platforms for drug screening and efficacy testing. Real-time monitoring of 3D cultures allows for the assessment of dynamic cellular behaviors, such as proliferation, migration, and interaction (<xref ref-type="bibr" rid="B19">De Leon et al., 2020</xref>). This capability is instrumental in studying complex phenomena like angiogenesis and tumor invasion, providing insights into disease mechanisms and potential therapeutic interventions.</p>
<p>Progression models enable the evaluation of treatment responses and the identification of novel therapeutic targets, contributing to advancements in precision medicine and personalized therapies (<xref ref-type="bibr" rid="B80">Xia et al., 2019</xref>). Furthermore, these models aid in deciphering intricate cellular signaling pathways involved in disease progression, paving the way for targeted interventions. Accurate measurement of structural changes in 3D cultures requires precise labeling techniques to track cell proliferation and migration over time (<xref ref-type="bibr" rid="B86">Zhang et al., 2019</xref>). Various labeling methods, such as fluorescent proteins and dyes, enable researchers to monitor multiple cell types simultaneously, facilitating comprehensive analyses of complex cellular interactions (<xref ref-type="bibr" rid="B54">Linsley et al., 2019</xref>).</p>
</sec>
<sec id="s1-2">
<title>3D constructs</title>
<p>Compared to traditional 2D cell cultures, 3D scaffolds provide a more realistic environment for cellular growth and interaction (<xref ref-type="bibr" rid="B41">Gupta et al., 2019</xref>). Crafted from diverse materials, these structures offer controlled porosity, permeability, surface chemistry, and mechanical properties, closely resembling the native extracellular matrix (ECM) that supports cellular organization in tissues (<xref ref-type="bibr" rid="B9">Bayir et al., 2019</xref>; <xref ref-type="bibr" rid="B45">Huang et al., 2020</xref>). This porous network not only supports cellular growth but also facilitates nutrient and oxygen diffusion, essential for maintaining cell viability and function (<xref ref-type="bibr" rid="B74">Terrell et al., 2020</xref>).</p>
<p>Fabricating these scaffolds entails various techniques, each tailored to achieve specific structural and mechanical properties (<xref ref-type="bibr" rid="B4">Ashok et al., 2020</xref>). Freeze-drying, for instance, utilizes sublimation to create a porous scaffold from a frozen solution, while electrospinning produces fibrous scaffolds through the application of electrostatic forces (<xref ref-type="bibr" rid="B27">Fan et al., 2019</xref>). The applications of 3D scaffolds are vast, spanning both tissue engineering and cell culture research. In tissue engineering, these scaffolds serve as a scaffold for the regeneration of damaged organs and tissues. By seeding scaffolds with appropriate cells and growth factors, researchers aim to facilitate tissue repair and functional restoration.</p>
<p>Beyond tissue regeneration, 3D scaffolds play a pivotal role in advancing our understanding of disease mechanisms and cell biology. By providing a more physiologically relevant environment, these scaffolds enable researchers to study cell-cell interactions, drug responses, and disease progression with greater accuracy. 3D scaffolds stand as indispensable tools in tissue engineering and cell culture for studying cellular behavior and advancing regenerative medicine.</p>
</sec>
<sec id="s1-3">
<title>Cells</title>
<p>Stem cells, particularly pluripotent stem cells (PSCs), have garnered immense interest due to their ability to generate various cell types and their potential in regenerative medicine (<xref ref-type="bibr" rid="B17">Costamagna et al., 2019</xref>; <xref ref-type="bibr" rid="B77">Turco and Moffett, 2019</xref>). They offer promising avenues for medical innovation, including drug discovery, cell therapy, and tissue regeneration (<xref ref-type="bibr" rid="B3">Artero Castro et al., 2019</xref>; <xref ref-type="bibr" rid="B71">Srivastava and Kilian, 2019</xref>). Utilizing advanced 3D cell platforms, researchers have made significant strides in understanding cell signaling and tissue development, particularly in fields.</p>
<p>Culturing cells in 3D models has emerged as a vital tool, providing results that closely mimic natural conditions and aiding in the translation of research findings into clinical applications (<xref ref-type="bibr" rid="B1">Alagarsamy et al., 2019</xref>; <xref ref-type="bibr" rid="B7">Balak et al., 2019</xref>; <xref ref-type="bibr" rid="B15">Chen and Schoen, 2019</xref>; <xref ref-type="bibr" rid="B36">Gibbs et al., 2019</xref>; <xref ref-type="bibr" rid="B39">Gopalakrishnan, 2019</xref>; <xref ref-type="bibr" rid="B57">Meivar-Levy and Ferber, 2019</xref>; <xref ref-type="bibr" rid="B65">Roberts et al., 2019</xref>; <xref ref-type="bibr" rid="B62">Nguyen et al., 2020</xref>; <xref ref-type="bibr" rid="B63">Raimondi et al., 2020</xref>). These models offer a more realistic representation of cellular behavior, ensuring better predictability when moving from the laboratory to real-world settings. Autologous, allogeneic, and xenogeneic cells are employed, with autologous cells preferred to mitigate the risk of rejection (<xref ref-type="bibr" rid="B16">Collins et al., 2020</xref>).</p>
<p>Adipose-derived stem cells (ASCs) have emerged as a significant player in regenerative medicine, offering several advantages over other sources such as bone marrow-derived mesenchymal stem cells (MSCs) (<xref ref-type="bibr" rid="B66">Ryu et al., 2019</xref>). ASCs, found within adipose tissue, boast higher yields and greater resistance to senescence, making them an attractive option for therapeutic applications (<xref ref-type="bibr" rid="B68">Seo et al., 2019</xref>). However, challenges persist in standardizing isolation methods and understanding their precise characteristics. The unique characteristics of ASCs vary depending on the tissue type and isolation method employed. Techniques like power-assisted liposuction have shown promising results in yielding high-quality ASCs, underscoring the importance of optimization in isolation protocols. Research continues to elucidate ASC behavior and identify specific markers to distinguish them from other cell types accurately.</p>
<p>Despite the progress made in harnessing the potential of stem cells and ASCs, several hurdles remain to be addressed. Standardization of isolation methods, precise differentiation instructions, and clarification of cell characteristics are crucial areas requiring further investigation. Nevertheless, the ongoing research holds significant promise for revolutionizing medical treatments and offering hope to patients with various degenerative diseases and injuries (<xref ref-type="bibr" rid="B72">Sthijns et al., 2019</xref>).</p>
</sec>
<sec id="s1-4">
<title>Medical applications</title>
<p>Transitioning from traditional 2D cell culture systems to more advanced 3D approaches represents a significant step towards understanding cellular behavior within a physiologically relevant context (<xref ref-type="bibr" rid="B61">Ndyabawe and Kisaalita, 2019</xref>; <xref ref-type="bibr" rid="B46">Jensen and Teng, 2020</xref>). 3D culture methods offer a more accurate representation of <italic>in vivo</italic> conditions, bridging the gap between conventional cell culture systems and the intricate physiology of living organisms (<xref ref-type="fig" rid="F2">Figure 2</xref>). This advancement is particularly crucial in the medical research, where cellular interactions and the microenvironment play pivotal roles in tumorigenesis (<xref ref-type="bibr" rid="B14">Chaicharoenaudomrung et al., 2019</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>The pictures show: <bold>(A)</bold> a defect after oncologic surgery, and <bold>(B)</bold> a 3D bioprinted scaffold (PCL/PLA, MediFab Inc.) for reconstruction. PLA, polylactic acid; PCL, polycaprolactone.</p>
</caption>
<graphic xlink:href="fbioe-12-1491669-g002.tif"/>
</fig>
<p>These benefits in tissue engineering and regenerative medicine enable 3D culture to be considered for various clinical applications (<xref ref-type="table" rid="T1">Table 1</xref>). The previous studies showed the development of 3D bioprinted skin tissue, adipose microtissues, and bone scaffolds, demonstrating substantial improvements in cell viability, differentiation, and functionality (<xref ref-type="bibr" rid="B35">Gholipourmalekabadi et al., 2018</xref>; <xref ref-type="bibr" rid="B82">Yan et al., 2019</xref>; <xref ref-type="bibr" rid="B83">Yang et al., 2021</xref>; <xref ref-type="bibr" rid="B52">Li et al., 2024</xref>). Studies on esophageal, gastric, and intestinal organoids provide insights into stem cell potential and disease modeling, revealing the intricate processes of tissue development and regeneration (<xref ref-type="bibr" rid="B70">Spence et al., 2011</xref>; <xref ref-type="bibr" rid="B20">DeWard et al., 2014</xref>; <xref ref-type="bibr" rid="B56">McCracken et al., 2014</xref>). The generation of vascularized liver buds, lung organoids, and pancreatic organoids underscores the progress in creating functional human tissues for therapeutic applications, offering promising avenues for treating related diseases (<xref ref-type="bibr" rid="B73">Takebe et al., 2013</xref>; <xref ref-type="bibr" rid="B24">Dye et al., 2015</xref>; <xref ref-type="bibr" rid="B11">Boj et al., 2016</xref>). The researches on heart defect, prostate cancer, optic cup formation, inner ear sensory tissue, and lingual epithelium organoids emphasize the importance of organoid systems in understanding disease and developing personalized treatments. They suggested innovative approaches in heart patch, musculoskeletal tissue engineering, cartilage repair, and ophthalmopathy treatment, focusing on the potential of stem cell-derived tissues and hybrid scaffolds in regenerative medicine (<xref ref-type="bibr" rid="B25">Eiraku et al., 2011</xref>; <xref ref-type="bibr" rid="B44">Hisha et al., 2013</xref>; <xref ref-type="bibr" rid="B33">Gao et al., 2014</xref>; <xref ref-type="bibr" rid="B49">Koehler and Hashino, 2014</xref>; <xref ref-type="bibr" rid="B30">Fischer et al., 2023</xref>; <xref ref-type="bibr" rid="B69">Soucy et al., 2025</xref>). Some studies explore the possible usage of &#x3b2; -cell generated from human pluripotent stem cells to cure diabetes mellitus, the potential of salivary gland stem cell therapy for treating xerostomia, and the development of bioprinted human skin substitutes (<xref ref-type="bibr" rid="B51">Lee et al., 2014</xref>; <xref ref-type="bibr" rid="B60">Nanduri et al., 2014</xref>; <xref ref-type="bibr" rid="B58">Millman et al., 2016</xref>; <xref ref-type="bibr" rid="B8">Baltazar et al., 2023</xref>). The researches on liver organoids derived from primary human hepatocytes and the creation of hybrid scaffolds for musculoskeletal tissue demonstrate the ongoing efforts to enhance the complexity and functionality of engineered tissues (<xref ref-type="bibr" rid="B67">Salas-Silva et al., 2023</xref>; <xref ref-type="bibr" rid="B26">Enbergs et al., 2024</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>The clinical application of 3D cell culture in medical areas.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Researcher (year)</th>
<th align="center">Cell</th>
<th align="center">Condition</th>
<th align="center">Application</th>
<th align="center">References</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Gholipourmalekabadi M. (2018)</td>
<td align="left">ASC</td>
<td align="left">Burn</td>
<td align="left">Skin</td>
<td align="left">
<xref ref-type="bibr" rid="B35">Gholipourmalekabadi et al. (2018)</xref>
</td>
</tr>
<tr>
<td align="left">Yang F. (2021)</td>
<td align="left">ASC</td>
<td align="left">Cancer surgery</td>
<td align="left">Adipose tissue</td>
<td align="left">
<xref ref-type="bibr" rid="B83">Yang et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">Yan Y. (2019)</td>
<td align="left">MSC</td>
<td align="left">Trauma</td>
<td align="left">Bone</td>
<td align="left">
<xref ref-type="bibr" rid="B82">Yan et al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left">Li J. (2024)</td>
<td align="left">MSC</td>
<td align="left">Trauma</td>
<td align="left">Cartilage</td>
<td align="left">
<xref ref-type="bibr" rid="B52">Li et al. (2024)</xref>
</td>
</tr>
<tr>
<td align="left">DeWard A. D. (2014)</td>
<td align="left">Primary cell</td>
<td align="left">Barrett&#x2019;s esophagus</td>
<td align="left">Esophagus</td>
<td align="left">
<xref ref-type="bibr" rid="B20">DeWard et al. (2014)</xref>
</td>
</tr>
<tr>
<td align="left">McCracken K. W. (2014)</td>
<td align="left">iPSC</td>
<td align="left">Stomach cancer</td>
<td align="left">Stomach</td>
<td align="left">
<xref ref-type="bibr" rid="B56">McCracken et al. (2014)</xref>
</td>
</tr>
<tr>
<td align="left">Spence J. R. (2011)</td>
<td align="left">iPSC</td>
<td align="left">Inflammatory bowel disease</td>
<td align="left">Intestine</td>
<td align="left">
<xref ref-type="bibr" rid="B70">Spence et al. (2011)</xref>
</td>
</tr>
<tr>
<td align="left">Takebe T. (2013)</td>
<td align="left">iPSC</td>
<td align="left">Cystic fibrosis</td>
<td align="left">Liver</td>
<td align="left">
<xref ref-type="bibr" rid="B73">Takebe et al. (2013)</xref>
</td>
</tr>
<tr>
<td align="left">Dye B. R. (2015)</td>
<td align="left">iPSC</td>
<td align="left">Cystic fibrosis</td>
<td align="left">Lung</td>
<td align="left">
<xref ref-type="bibr" rid="B24">Dye et al. (2015)</xref>
</td>
</tr>
<tr>
<td align="left">Boj S. F. (2015)</td>
<td align="left">Primary cell</td>
<td align="left">Pancreas cancer</td>
<td align="left">Pancreas</td>
<td align="left">
<xref ref-type="bibr" rid="B11">Boj et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left">Fisher B. (2023)</td>
<td align="left">iPSC</td>
<td align="left">Heart defect</td>
<td align="left">Heart</td>
<td align="left">
<xref ref-type="bibr" rid="B30">Fischer et al. (2023)</xref>
</td>
</tr>
<tr>
<td align="left">Gao D. (2014)</td>
<td align="left">Primary cell</td>
<td align="left">Prostate cancer</td>
<td align="left">Prostate</td>
<td align="left">
<xref ref-type="bibr" rid="B33">Gao et al. (2014)</xref>
</td>
</tr>
<tr>
<td align="left">Eiraku M. (2011)</td>
<td align="left">ESC</td>
<td align="left">Retinitis pigmentosa</td>
<td align="left">Retina</td>
<td align="left">
<xref ref-type="bibr" rid="B25">Eiraku et al. (2011)</xref>
</td>
</tr>
<tr>
<td align="left">Soucy J. (2025)</td>
<td align="left">ESC</td>
<td align="left">Glaucoma</td>
<td align="left">Eye</td>
<td align="left">
<xref ref-type="bibr" rid="B69">Soucy et al. (2025)</xref>
</td>
</tr>
<tr>
<td align="left">Koehler K. R. (2014)</td>
<td align="left">ESC</td>
<td align="left">Amblyacousia</td>
<td align="left">Inner ear organ</td>
<td align="left">
<xref ref-type="bibr" rid="B49">Koehler and Hashino (2014)</xref>
</td>
</tr>
<tr>
<td align="left">Hisha H. (2013)</td>
<td align="left">ESC</td>
<td align="left">Tongue cancer</td>
<td align="left">Tongue</td>
<td align="left">
<xref ref-type="bibr" rid="B44">Hisha et al. (2013)</xref>
</td>
</tr>
<tr>
<td align="left">Millman J. R. (2016)</td>
<td align="left">iPSC</td>
<td align="left">Diabetes mellitus</td>
<td align="left">&#x3b2; cell</td>
<td align="left">
<xref ref-type="bibr" rid="B58">Millman et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left">Nanduri L. S. Y. (2014)</td>
<td align="left">Primary cell</td>
<td align="left">Hyposalivation</td>
<td align="left">Salivary gland</td>
<td align="left">
<xref ref-type="bibr" rid="B60">Nanduri et al. (2014)</xref>
</td>
</tr>
<tr>
<td align="left">Lee V. (2014)</td>
<td align="left">Cell line</td>
<td align="left">Burn</td>
<td align="left">Skin</td>
<td align="left">
<xref ref-type="bibr" rid="B51">Lee et al. (2014)</xref>
</td>
</tr>
<tr>
<td align="left">Baltazar T. (2022)</td>
<td align="left">ESC</td>
<td align="left">Skin cancer</td>
<td align="left">Skin</td>
<td align="left">
<xref ref-type="bibr" rid="B8">Baltazar et al. (2023)</xref>
</td>
</tr>
<tr>
<td align="left">Salas-Silva S. (2023)</td>
<td align="left">iPSC</td>
<td align="left">Liver disease</td>
<td align="left">Liver</td>
<td align="left">
<xref ref-type="bibr" rid="B67">Salas-Silva et al. (2023)</xref>
</td>
</tr>
<tr>
<td align="left">Enbergs S. (2024)</td>
<td align="left">Cell line</td>
<td align="left">Trauma</td>
<td align="left">Muscle</td>
<td align="left">
<xref ref-type="bibr" rid="B26">Enbergs et al. (2024)</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>ASC, adipose-derived stem cell; MSC, mesenchymal stem cell; iPSC, induced pluripotent stem cell; ESC, embryonic stem cell.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>One of the primary advantages of 3D culture over 2D systems is the preservation of critical extracellular matrix components and cell-cell or cell-matrix interactions (<xref ref-type="bibr" rid="B64">Ravi et al., 2015</xref>; <xref ref-type="bibr" rid="B38">Gonzalez Diaz et al., 2019</xref>; <xref ref-type="bibr" rid="B76">Tomas-Bort et al., 2020</xref>). These interactions are essential for various cellular processes, including differentiation, proliferation, and the expression of specific phenotypic traits. By maintaining these critical elements, 3D culture systems provide researchers with a more holistic view of cellular behavior, allowing for more accurate predictions of <italic>in vivo</italic> responses to various stimuli and treatments.</p>
<p>Studies have demonstrated that 3D tissue cultures can offer novel insights into tumorigenic mechanisms that may not be apparent in conventional 2D models (<xref ref-type="bibr" rid="B55">Liu et al., 2019</xref>; <xref ref-type="bibr" rid="B65">Roberts et al., 2019</xref>; <xref ref-type="bibr" rid="B6">Bahcecioglu et al., 2020</xref>; <xref ref-type="bibr" rid="B85">Zhang et al., 2020</xref>). The three-dimensional arrangement of cells in these cultures closely mimics the architecture of tumors <italic>in vivo</italic>, facilitating the study of complex processes such as invasion, metastasis, and drug resistance. Additionally, 3D culture systems enable the examination of dynamic cellular behaviors, such as migration and morphogenesis, which are challenging to replicate in 2D environments (<xref ref-type="bibr" rid="B81">Yamada and Sixt, 2019</xref>).</p>
<p>Moreover, 3D culture methods offer enhanced biomarker expression, providing researchers with valuable tools for studying cellular functions and interactions (<xref ref-type="bibr" rid="B64">Ravi et al., 2015</xref>). By accurately recapitulating the native cellular microenvironment, these systems enable the investigation of signaling pathways and regulatory mechanisms that are crucial for understanding disease progression and treatment response (<xref ref-type="bibr" rid="B38">Gonzalez Diaz et al., 2019</xref>). This improved biomarker expression also enhances the sensitivity and specificity of assays, leading to more reliable experimental results.</p>
<p>In addition to their utility in basic research, 3D culture systems hold promise for applications in drug development and personalized medicine (<xref ref-type="bibr" rid="B54">Linsley et al., 2019</xref>; <xref ref-type="bibr" rid="B12">Brancato et al., 2020</xref>; <xref ref-type="bibr" rid="B28">Fernandes et al., 2020</xref>; <xref ref-type="bibr" rid="B31">Fisher and Rao, 2020</xref>). These systems can serve as cost-effective screening platforms for identifying potential therapeutic agents and predicting their efficacy and safety profiles. By incorporating patient-derived cells into 3D cultures, researchers can tailor treatment strategies to individual patients, improving the likelihood of successful outcomes and minimizing adverse effects.</p>
<p>Overall, the transition from 2D to 3D cell culture represents a paradigm shift in biomedical research, offering researchers a more physiologically relevant model system for studying cellular behavior and disease mechanisms (<xref ref-type="bibr" rid="B39">Gopalakrishnan, 2019</xref>). By preserving critical cellular interactions and microenvironmental cues, 3D culture methods offer a more accurate representation of <italic>in vivo</italic> conditions. These technologies hold the potential to revolutionize medical fields, from cancer biology to regenerative medicine, paving the way for new diagnostic and therapeutic strategies.</p>
</sec>
</sec>
<sec id="s2">
<title>Limitations</title>
<p>Limitations in 3D cell culture models present significant challenges both in terms of usability and standardization (<xref ref-type="bibr" rid="B48">Kim et al., 2020</xref>). Cultivating cells in three dimensions demands a certain level of expertise due to the necessity of forming cell aggregates, which complicates tasks such as exchanging culture medium and maintaining extracellular matrix integrity, leading to potential issues with cross-contamination during experimentation (<xref ref-type="bibr" rid="B12">Brancato et al., 2020</xref>). Addressing these challenges may necessitate the development of culture vessels that facilitate convenient medium exchange, thereby simplifying the experimental process (<xref ref-type="bibr" rid="B37">Gleave et al., 2020</xref>).</p>
<p>Standardization of analysis poses another significant challenge in the context of 3D cell culture models (<xref ref-type="bibr" rid="B85">Zhang et al., 2020</xref>). The three-dimensional nature of cell aggregates in 3D culture models introduces variability in the diffusion and penetration of these reagents (<xref ref-type="bibr" rid="B18">Czaplinska et al., 2019</xref>; <xref ref-type="bibr" rid="B16">Collins et al., 2020</xref>; <xref ref-type="bibr" rid="B32">Foglietta et al., 2020</xref>). Currently, common methods involve staining and measuring the size of cell aggregates, but these fail to accurately represent the activity of cells within these aggregates (<xref ref-type="bibr" rid="B4">Ashok et al., 2020</xref>). Efforts are underway to precisely measure cellular activity within aggregates using techniques such as tissue clearing or confocal microscopy (<xref ref-type="bibr" rid="B47">Ji et al., 2019</xref>; <xref ref-type="bibr" rid="B19">De Leon et al., 2020</xref>; <xref ref-type="bibr" rid="B32">Foglietta et al., 2020</xref>). However, standardization of these techniques remains elusive.</p>
<p>Continued research and development efforts are imperative to address these challenges and standardize the technology. Once these issues are resolved, 3D cell culture models, with their excellent biocompatibility, hold tremendous promise for applications in precision medicine, the pharmaceutical and biotechnology industries, and basic research. With further refinement and standardization, these models could revolutionize various fields by providing more physiologically relevant platforms for drug discovery, toxicity testing, disease modeling, and surgical application, ultimately leading to improved outcomes for patients (<xref ref-type="bibr" rid="B5">Ashraf et al., 2019</xref>).</p>
</sec>
<sec sec-type="conclusion" id="s3">
<title>Conclusion</title>
<p>3D cell culture models offer a promising approach to studying cell behavior <italic>in vitro</italic>, providing a more physiologically relevant environment compared to traditional 2D cultures. Despite the challenges, advancements in 3D cell culture technology hold great potential for revolutionizing medical research and clinical practice.</p>
</sec>
</body>
<back>
<sec sec-type="author-contributions" id="s4">
<title>Author contributions</title>
<p>CP: Conceptualization, Funding acquisition, Writing&#x2013;review and editing. JP: Funding acquisition, Writing&#x2013;review and editing. YS: Conceptualization, Data curation, Formal Analysis, Writing&#x2013;original draft.</p>
</sec>
<sec sec-type="funding-information" id="s5">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was also supported by a grant of the Korea Health Technology R&#x26;D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (Grant No. HI21C1847).</p>
</sec>
<ack>
<p>During the preparation of this work, the authors used the GPT-3.5 architecture (OpenAI, California, USA) to ensure natural language flow and nuances. After utilizing this service, the authors reviewed and edited the content as needed and take full responsibility for the publication&#x2019;s content.</p>
</ack>
<sec sec-type="COI-statement" id="s6">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s7">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alagarsamy</surname>
<given-names>K. N.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Srivastava</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Desiderio</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Dhingra</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Application of injectable hydrogels for cardiac stem cell therapy and tissue engineering</article-title>. <source>Rev. Cardiovasc Med.</source> <volume>20</volume> (<issue>4</issue>), <fpage>221</fpage>&#x2013;<lpage>230</lpage>. <pub-id pub-id-type="doi">10.31083/j.rcm.2019.04.534</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alghuwainem</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Alshareeda</surname>
<given-names>A. T.</given-names>
</name>
<name>
<surname>Alsowayan</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Scaffold-Free 3-D cell sheet technique bridges the gap between 2-D cell culture and animal models</article-title>. <source>Int. J. Mol. Sci.</source> <volume>20</volume> (<issue>19</issue>), <fpage>4926</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20194926</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Artero Castro</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rodriguez Jimenez</surname>
<given-names>F. J.</given-names>
</name>
<name>
<surname>Jendelova</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Erceg</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Deciphering retinal diseases through the generation of three dimensional stem cell-derived organoids: concise Review</article-title>. <source>Stem Cells</source> <volume>37</volume> (<issue>12</issue>), <fpage>1496</fpage>&#x2013;<lpage>1504</lpage>. <pub-id pub-id-type="doi">10.1002/stem.3089</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashok</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Choudhury</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hunziker</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Towards manufacturing of human organoids</article-title>. <source>Biotechnol. Adv.</source> <volume>39</volume>, <fpage>107460</fpage>. <pub-id pub-id-type="doi">10.1016/j.biotechadv.2019.107460</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashraf</surname>
<given-names>M. N.</given-names>
</name>
<name>
<surname>Asghar</surname>
<given-names>M. W.</given-names>
</name>
<name>
<surname>Rong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Doschak</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Kiang</surname>
<given-names>T. K. L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Advanced <italic>in vitro</italic> HepaRG culture systems for xenobiotic metabolism and toxicity characterization</article-title>. <source>Eur. J. Drug Metab. Pharmacokinet.</source> <volume>44</volume> (<issue>4</issue>), <fpage>437</fpage>&#x2013;<lpage>458</lpage>. <pub-id pub-id-type="doi">10.1007/s13318-018-0533-3</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bahcecioglu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Basara</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>B. W.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zorlutuna</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Breast cancer models: engineering the tumor microenvironment</article-title>. <source>Acta Biomater.</source> <volume>106</volume>, <fpage>1</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2020.02.006</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balak</surname>
<given-names>J. R. A.</given-names>
</name>
<name>
<surname>Juksar</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Carlotti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lo Nigro</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>de Koning</surname>
<given-names>E. J. P.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Organoids from the human fetal and adult pancreas</article-title>. <source>Curr. Diab Rep.</source> <volume>19</volume> (<issue>12</issue>), <fpage>160</fpage>. <pub-id pub-id-type="doi">10.1007/s11892-019-1261-z</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baltazar</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Moncayo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Merola</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Albanna</surname>
<given-names>M. Z.</given-names>
</name>
<name>
<surname>Saltzman</surname>
<given-names>W. M.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>3D bioprinting of an implantable xeno-free vascularized human skin graft</article-title>. <source>Bioeng. Transl. Med.</source> <volume>8</volume> (<issue>1</issue>), <fpage>e10324</fpage>. <pub-id pub-id-type="doi">10.1002/btm2.10324</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bayir</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sendemir</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Missirlis</surname>
<given-names>Y. F.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Mechanobiology of cells and cell systems, such as organoids</article-title>. <source>Biophys. Rev.</source> <volume>11</volume> (<issue>5</issue>), <fpage>721</fpage>&#x2013;<lpage>728</lpage>. <pub-id pub-id-type="doi">10.1007/s12551-019-00590-7</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bertucci</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Koppes</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dumont</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Koppes</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Neural responses to electrical stimulation in 2D and 3D <italic>in vitro</italic> environments</article-title>. <source>Brain Res. Bull.</source> <volume>152</volume>, <fpage>265</fpage>&#x2013;<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2019.07.016</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boj</surname>
<given-names>S. F.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>C. I.</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Engle</surname>
<given-names>D. D.</given-names>
</name>
<name>
<surname>Tuveson</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Clevers</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Model organoids provide new research opportunities for ductal pancreatic cancer</article-title>. <source>Mol. Cell Oncol.</source> <volume>3</volume> (<issue>1</issue>), <fpage>e1014757</fpage>. <pub-id pub-id-type="doi">10.1080/23723556.2015.1014757</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brancato</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Correlo</surname>
<given-names>V. M.</given-names>
</name>
<name>
<surname>Reis</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Kundu</surname>
<given-names>S. C.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Could 3D models of cancer enhance drug screening?</article-title> <source>Biomaterials</source> <volume>232</volume>, <fpage>119744</fpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2019.119744</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calejo</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Costa-Almeida</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Reis</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Gomes</surname>
<given-names>M. E.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Enthesis tissue engineering: biological requirements meet at the interface</article-title>. <source>Tissue Eng. Part B Rev.</source> <volume>25</volume> (<issue>4</issue>), <fpage>330</fpage>&#x2013;<lpage>356</lpage>. <pub-id pub-id-type="doi">10.1089/ten.TEB.2018.0383</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaicharoenaudomrung</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kunhorm</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Noisa</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Three-dimensional cell culture systems as an <italic>in vitro</italic> platform for cancer and stem cell modeling</article-title>. <source>World J. Stem Cells</source> <volume>11</volume> (<issue>12</issue>), <fpage>1065</fpage>&#x2013;<lpage>1083</lpage>. <pub-id pub-id-type="doi">10.4252/wjsc.v11.i12.1065</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schoen</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Air-liquid interface cell culture: from airway epithelium to the female reproductive tract</article-title>. <source>Reprod. Domest. Anim.</source> <volume>54</volume> (<issue>Suppl. 3</issue>), <fpage>38</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1111/rda.13481</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collins</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Miles</surname>
<given-names>G. J.</given-names>
</name>
<name>
<surname>Wood</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>MacFarlane</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pritchard</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Moss</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Patient-derived explants, xenografts and organoids: 3-dimensional patient-relevant pre-clinical models in endometrial cancer</article-title>. <source>Gynecol. Oncol.</source> <volume>156</volume> (<issue>1</issue>), <fpage>251</fpage>&#x2013;<lpage>259</lpage>. <pub-id pub-id-type="doi">10.1016/j.ygyno.2019.11.020</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costamagna</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Andreoli</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Corti</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Faravelli</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>iPSCs-based neural 3D systems: a multidimensional approach for disease modeling and drug discovery</article-title>. <source>Cells</source> <volume>8</volume> (<issue>11</issue>), <fpage>1438</fpage>. <pub-id pub-id-type="doi">10.3390/cells8111438</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Czaplinska</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Elingaard-Larsen</surname>
<given-names>L. O.</given-names>
</name>
<name>
<surname>Rolver</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Severin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>S. F.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>3D multicellular models to study the regulation and roles of acid-base transporters in breast cancer</article-title>. <source>Biochem. Soc. Trans.</source> <volume>47</volume> (<issue>6</issue>), <fpage>1689</fpage>&#x2013;<lpage>1700</lpage>. <pub-id pub-id-type="doi">10.1042/BST20190131</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Leon</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Pupovac</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>McArthur</surname>
<given-names>S. L.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Three-Dimensional (3D) cell culture monitoring: opportunities and challenges for impedance spectroscopy</article-title>. <source>Biotechnol. Bioeng.</source> <volume>117</volume> (<issue>4</issue>), <fpage>1230</fpage>&#x2013;<lpage>1240</lpage>. <pub-id pub-id-type="doi">10.1002/bit.27270</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeWard</surname>
<given-names>A. D.</given-names>
</name>
<name>
<surname>Cramer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lagasse</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Cellular heterogeneity in the mouse esophagus implicates the presence of a nonquiescent epithelial stem cell population</article-title>. <source>Cell Rep.</source> <volume>9</volume> (<issue>2</issue>), <fpage>701</fpage>&#x2013;<lpage>711</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2014.09.027</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diaz-Rodriguez</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lopez-Alvarez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Serra</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Landin</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Current stage of marine ceramic grafts for 3D bone tissue regeneration</article-title>. <source>Mar. Drugs</source> <volume>17</volume> (<issue>8</issue>), <fpage>471</fpage>. <pub-id pub-id-type="doi">10.3390/md17080471</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dumont</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Heremans</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Van Gorp</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Vergote</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Timmerman</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Organoids of epithelial ovarian cancer as an emerging preclinical <italic>in vitro</italic> tool: a review</article-title>. <source>J. Ovarian Res.</source> <volume>12</volume> (<issue>1</issue>), <fpage>105</fpage>. <pub-id pub-id-type="doi">10.1186/s13048-019-0577-2</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duval</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Grover</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>L. H.</given-names>
</name>
<name>
<surname>Mou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pegoraro</surname>
<given-names>A. F.</given-names>
</name>
<name>
<surname>Fredberg</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Modeling physiological events in 2D vs. 3D cell culture</article-title>. <source>Physiol. (Bethesda)</source> <volume>32</volume> (<issue>4</issue>), <fpage>266</fpage>&#x2013;<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1152/physiol.00036.2016</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dye</surname>
<given-names>B. R.</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Ferguson</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Nagy</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Dyal</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>
<italic>In vitro</italic> generation of human pluripotent stem cell derived lung organoids</article-title>. <source>Elife</source> <volume>4</volume>, <fpage>e05098</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.05098</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eiraku</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takata</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ishibashi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kawada</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sakakura</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Okuda</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Self-organizing optic-cup morphogenesis in three-dimensional culture</article-title>. <source>Nature</source> <volume>472</volume> (<issue>7341</issue>), <fpage>51</fpage>&#x2013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1038/nature09941</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Enbergs</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shopperly</surname>
<given-names>L. K.</given-names>
</name>
<name>
<surname>Engels</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Laue</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ertel</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Sittinger</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Additively manufactured 3D clamp-culture system for the investigation of material-cell interactions in multi-material hybrid scaffolds for musculoskeletal tissue defects</article-title>. <source>J. Biomed. Mater Res. B Appl. Biomater.</source> <volume>112</volume> (<issue>11</issue>), <fpage>e35494</fpage>. <pub-id pub-id-type="doi">10.1002/jbm.b.35494</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Staufer</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Accardo</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Engineered 3D polymer and hydrogel microenvironments for cell culture applications</article-title>. <source>Bioeng. (Basel)</source> <volume>6</volume> (<issue>4</issue>), <fpage>113</fpage>. <pub-id pub-id-type="doi">10.3390/bioengineering6040113</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandes</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Canadas</surname>
<given-names>R. F.</given-names>
</name>
<name>
<surname>Reis</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Dynamic culture systems and 3D interfaces models for cancer drugs testing</article-title>. <source>Adv. Exp. Med. Biol.</source> <volume>1230</volume>, <fpage>137</fpage>&#x2013;<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-030-36588-2_9</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferreira</surname>
<given-names>L. P.</given-names>
</name>
<name>
<surname>Gaspar</surname>
<given-names>V. M.</given-names>
</name>
<name>
<surname>Mano</surname>
<given-names>J. F.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Design of spherically structured 3D <italic>in vitro</italic> tumor models -Advances and prospects</article-title>. <source>Acta Biomater.</source> <volume>75</volume>, <fpage>11</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2018.05.034</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fischer</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gwinner</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Gepp</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Schulz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Danz</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Dehne</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>A highly versatile biopolymer-based platform for the maturation of human pluripotent stem cell-derived cardiomyocytes enables functional analysis <italic>in vitro</italic> and 3D printing of heart patches</article-title>. <source>J. Biomed. Mater Res. A</source> <volume>111</volume> (<issue>10</issue>), <fpage>1600</fpage>&#x2013;<lpage>1615</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.a.37558</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fisher</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>S. S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Three-dimensional culture models to study drug resistance in breast cancer</article-title>. <source>Biotechnol. Bioeng.</source> <volume>117</volume> (<issue>7</issue>), <fpage>2262</fpage>&#x2013;<lpage>2278</lpage>. <pub-id pub-id-type="doi">10.1002/bit.27356</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foglietta</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Canaparo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Muccioli</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Terreno</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Serpe</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Methodological aspects and pharmacological applications of three-dimensional cancer cell cultures and organoids</article-title>. <source>Life Sci.</source> <volume>254</volume>, <fpage>117784</fpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2020.117784</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Vela</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Sboner</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Iaquinta</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Karthaus</surname>
<given-names>W. R.</given-names>
</name>
<name>
<surname>Gopalan</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Organoid cultures derived from patients with advanced prostate cancer</article-title>. <source>Cell</source> <volume>159</volume> (<issue>1</issue>), <fpage>176</fpage>&#x2013;<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.08.016</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hornicek</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Three-dimensional (3D) culture in sarcoma research and the clinical significance</article-title>. <source>Biofabrication</source> <volume>9</volume> (<issue>3</issue>), <fpage>032003</fpage>. <pub-id pub-id-type="doi">10.1088/1758-5090/aa7fdb</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gholipourmalekabadi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Seifalian</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Urbanska</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Omrani</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Hardy</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>Madjd</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>3D protein-based bilayer artificial skin for the guided scarless healing of third-degree burn wounds <italic>in vivo</italic>
</article-title>. <source>Biomacromolecules</source> <volume>19</volume> (<issue>7</issue>), <fpage>2409</fpage>&#x2013;<lpage>2422</lpage>. <pub-id pub-id-type="doi">10.1021/acs.biomac.7b01807</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gibbs</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Roffel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gasser</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Biology of soft tissue repair: gingival epithelium in wound healing and attachment to the tooth and abutment surface</article-title>. <source>Eur. Cell Mater</source> <volume>38</volume>, <fpage>63</fpage>&#x2013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.22203/eCM.v038a06</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gleave</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Ci</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>A synopsis of prostate organoid methodologies, applications, and limitations</article-title>. <source>Prostate</source> <volume>80</volume> (<issue>6</issue>), <fpage>518</fpage>&#x2013;<lpage>526</lpage>. <pub-id pub-id-type="doi">10.1002/pros.23966</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonzalez Diaz</surname>
<given-names>E. C.</given-names>
</name>
<name>
<surname>Sinha</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Avedian</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Tissue-engineered 3D models for elucidating primary and metastatic bone cancer progression</article-title>. <source>Acta Biomater.</source> <volume>99</volume>, <fpage>18</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2019.08.020</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gopalakrishnan</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The emergence of stem cell-based brain organoids: trends and challenges</article-title>. <source>Bioessays</source> <volume>41</volume> (<issue>8</issue>), <fpage>e1900011</fpage>. <pub-id pub-id-type="doi">10.1002/bies.201900011</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Bioengineered microenvironment to culture early embryos</article-title>. <source>Cell Prolif.</source> <volume>53</volume> (<issue>2</issue>), <fpage>e12754</fpage>. <pub-id pub-id-type="doi">10.1111/cpr.12754</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Renugopalakrishnan</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Liepmann</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Paulmurugan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Malhotra</surname>
<given-names>B. D.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Cell-based biosensors: recent trends, challenges and future perspectives</article-title>. <source>Biosens. Bioelectron.</source> <volume>141</volume>, <fpage>111435</fpage>. <pub-id pub-id-type="doi">10.1016/j.bios.2019.111435</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ham</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lever</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Reagan</surname>
<given-names>M. R.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>
<italic>In vitro</italic> 3D cultures to reproduce the bone marrow niche</article-title>. <source>JBMR Plus</source> <volume>3</volume> (<issue>10</issue>), <fpage>e10228</fpage>. <pub-id pub-id-type="doi">10.1002/jbm4.10228</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haycock</surname>
<given-names>J. W.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>3D cell culture: a review of current approaches and techniques</article-title>. <source>Methods Mol. Biol.</source> <volume>695</volume>, <fpage>1</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-60761-984-0_1</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hisha</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kanno</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tokuyama</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Komai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ohe</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Establishment of a novel lingual organoid culture system: generation of organoids having mature keratinized epithelium from adult epithelial stem cells</article-title>. <source>Sci. Rep.</source> <volume>3</volume>, <fpage>3224</fpage>. <pub-id pub-id-type="doi">10.1038/srep03224</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Abdalla</surname>
<given-names>A. M. E.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Biopolymer-based microcarriers for three-dimensional cell culture and engineered tissue formation</article-title>. <source>Int. J. Mol. Sci.</source> <volume>21</volume> (<issue>5</issue>), <fpage>1895</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21051895</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jensen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Teng</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Is it time to start transitioning from 2D to 3D cell culture?</article-title> <source>Front. Mol. Biosci.</source> <volume>7</volume>, <fpage>33</fpage>. <pub-id pub-id-type="doi">10.3389/fmolb.2020.00033</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ji</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sameni</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Osuala</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Moin</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mattingly</surname>
<given-names>R. R.</given-names>
</name>
<name>
<surname>Sloane</surname>
<given-names>B. F.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Spatio-temporal modeling and live-cell imaging of proteolysis in the 4D microenvironment of breast cancer</article-title>. <source>Cancer Metastasis Rev.</source> <volume>38</volume> (<issue>3</issue>), <fpage>445</fpage>&#x2013;<lpage>454</lpage>. <pub-id pub-id-type="doi">10.1007/s10555-019-09810-8</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Koo</surname>
<given-names>B. K.</given-names>
</name>
<name>
<surname>Knoblich</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Human organoids: model systems for human biology and medicine</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>21</volume>, <fpage>571</fpage>&#x2013;<lpage>584</lpage>. <pub-id pub-id-type="doi">10.1038/s41580-020-0259-3</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koehler</surname>
<given-names>K. R.</given-names>
</name>
<name>
<surname>Hashino</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>3D mouse embryonic stem cell culture for generating inner ear organoids</article-title>. <source>Nat. Protoc.</source> <volume>9</volume> (<issue>6</issue>), <fpage>1229</fpage>&#x2013;<lpage>1244</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2014.100</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>S. K.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Liver microsystems <italic>in vitro</italic> for drug response</article-title>. <source>J. Biomed. Sci.</source> <volume>26</volume> (<issue>1</issue>), <fpage>88</fpage>. <pub-id pub-id-type="doi">10.1186/s12929-019-0575-0</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Trasatti</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Bjornsson</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>T. N.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Design and fabrication of human skin by three-dimensional bioprinting</article-title>. <source>Tissue Eng. Part C Methods</source> <volume>20</volume> (<issue>6</issue>), <fpage>473</fpage>&#x2013;<lpage>484</lpage>. <pub-id pub-id-type="doi">10.1089/ten.TEC.2013.0335</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Quan</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>3D printed sodium alginate/gelatin/tannic acid/calcium chloride scaffolds laden bone marrow mesenchymal stem cells to repair defective thyroid cartilage plate</article-title>. <source>J. Biomater. Appl.</source>, <fpage>8853282241300587</fpage>. <pub-id pub-id-type="doi">10.1177/08853282241300587</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sved Skottvoll</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rayner</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pedersen-Bjergaard</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Krauss</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>3D cell culture models and organ-on-a-chip: meet separation science and mass spectrometry</article-title>. <source>Electrophoresis</source> <volume>41</volume> (<issue>1-2</issue>), <fpage>56</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1002/elps.201900170</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Linsley</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Reisine</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Finkbeiner</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Cell death assays for neurodegenerative disease drug discovery</article-title>. <source>Expert Opin. Drug Discov.</source> <volume>14</volume> (<issue>9</issue>), <fpage>901</fpage>&#x2013;<lpage>913</lpage>. <pub-id pub-id-type="doi">10.1080/17460441.2019.1623784</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Review on biofabrication and applications of heterogeneous tumor models</article-title>. <source>J. Tissue Eng. Regen. Med.</source> <volume>13</volume> (<issue>11</issue>), <fpage>2101</fpage>&#x2013;<lpage>2120</lpage>. <pub-id pub-id-type="doi">10.1002/term.2949</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCracken</surname>
<given-names>K. W.</given-names>
</name>
<name>
<surname>Cata</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Sinagoga</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Schumacher</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rockich</surname>
<given-names>B. E.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Modelling human development and disease in pluripotent stem-cell-derived gastric organoids</article-title>. <source>Nature</source> <volume>516</volume> (<issue>7531</issue>), <fpage>400</fpage>&#x2013;<lpage>404</lpage>. <pub-id pub-id-type="doi">10.1038/nature13863</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meivar-Levy</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ferber</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Liver to pancreas transdifferentiation</article-title>. <source>Curr. Diab Rep.</source> <volume>19</volume> (<issue>9</issue>), <fpage>76</fpage>. <pub-id pub-id-type="doi">10.1007/s11892-019-1198-2</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Millman</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Van Dervort</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gurtler</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pagliuca</surname>
<given-names>F. W.</given-names>
</name>
<name>
<surname>Melton</surname>
<given-names>D. A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Generation of stem cell-derived &#x3b2;-cells from patients with type 1 diabetes</article-title>. <source>Nat. Commun.</source> <volume>7</volume>, <fpage>11463</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms11463</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mofazzal Jahromi</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Abdoli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rahmanian</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bardania</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bayandori</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Moosavi Basri</surname>
<given-names>S. M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Microfluidic brain-on-a-chip: perspectives for mimicking neural system disorders</article-title>. <source>Mol. Neurobiol.</source> <volume>56</volume> (<issue>12</issue>), <fpage>8489</fpage>&#x2013;<lpage>8512</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-019-01653-2</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nanduri</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>Baanstra</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Faber</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rocchi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zwart</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>de Haan</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Purification and <italic>ex vivo</italic> expansion of fully functional salivary gland stem cells</article-title>. <source>Stem Cell Rep.</source> <volume>3</volume> (<issue>6</issue>), <fpage>957</fpage>&#x2013;<lpage>964</lpage>. <pub-id pub-id-type="doi">10.1016/j.stemcr.2014.09.015</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ndyabawe</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kisaalita</surname>
<given-names>W. S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Engineering microsystems to recapitulate brain physiology on a chip</article-title>. <source>Drug Discov. Today</source> <volume>24</volume> (<issue>9</issue>), <fpage>1725</fpage>&#x2013;<lpage>1730</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2019.06.008</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguyen</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>S. D. W.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Read</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Ahlenstiel</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>George</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Application of organoids in translational research of human diseases with a particular focus on gastrointestinal cancers</article-title>. <source>Biochim. Biophys. Acta Rev. Cancer</source> <volume>1873</volume> (<issue>2</issue>), <fpage>188350</fpage>. <pub-id pub-id-type="doi">10.1016/j.bbcan.2020.188350</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raimondi</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Donnaloja</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Barzaghini</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bocconi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Conci</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Parodi</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Bioengineering tools to speed up the discovery and preclinical testing of vaccines for SARS-CoV-2 and therapeutic agents for COVID-19</article-title>. <source>Theranostics</source> <volume>10</volume> (<issue>16</issue>), <fpage>7034</fpage>&#x2013;<lpage>7052</lpage>. <pub-id pub-id-type="doi">10.7150/thno.47406</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ravi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Paramesh</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Kaviya</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Anuradha</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Solomon</surname>
<given-names>F. D.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>3D cell culture systems: advantages and applications</article-title>. <source>J. Cell Physiol.</source> <volume>230</volume> (<issue>1</issue>), <fpage>16</fpage>&#x2013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.24683</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roberts</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Peyman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Speirs</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Current and emerging 3D models to study breast cancer</article-title>. <source>Adv. Exp. Med. Biol.</source> <volume>1152</volume>, <fpage>413</fpage>&#x2013;<lpage>427</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-030-20301-6_22</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ryu</surname>
<given-names>N. E.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Spheroid culture system methods and applications for mesenchymal stem cells</article-title>. <source>Cells</source> <volume>8</volume> (<issue>12</issue>), <fpage>1620</fpage>. <pub-id pub-id-type="doi">10.3390/cells8121620</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salas-Silva</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>T. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Seo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Human chemically-derived hepatic progenitors (hCdHs) as a source of liver organoid generation: application in regenerative medicine, disease modeling, and toxicology testing</article-title>. <source>Biomaterials</source> <volume>303</volume>, <fpage>122360</fpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2023.122360</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>T. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H. S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Current strategies to enhance adipose stem cell function: an update</article-title>. <source>Int. J. Mol. Sci.</source> <volume>20</volume> (<issue>15</issue>), <fpage>3827</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20153827</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soucy</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Malechka</surname>
<given-names>V. V.</given-names>
</name>
<name>
<surname>Baranov</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Retinal Ganglion cell transplantation: differentiation and quantification strategies</article-title>. <source>Methods Mol. Biol.</source> <volume>2858</volume>, <fpage>173</fpage>&#x2013;<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-0716-4140-8_15</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spence</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Mayhew</surname>
<given-names>C. N.</given-names>
</name>
<name>
<surname>Rankin</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Kuhar</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Vallance</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Tolle</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Directed differentiation of human pluripotent stem cells into intestinal tissue <italic>in vitro</italic>
</article-title>. <source>Nature</source> <volume>470</volume> (<issue>7332</issue>), <fpage>105</fpage>&#x2013;<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1038/nature09691</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srivastava</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kilian</surname>
<given-names>K. A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Micro-engineered models of development using induced pluripotent stem cells</article-title>. <source>Front. Bioeng. Biotechnol.</source> <volume>7</volume>, <fpage>357</fpage>. <pub-id pub-id-type="doi">10.3389/fbioe.2019.00357</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sthijns</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>LaPointe</surname>
<given-names>V. L. S.</given-names>
</name>
<name>
<surname>van Blitterswijk</surname>
<given-names>C. A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Building complex life through self-organization</article-title>. <source>Tissue Eng. Part A</source> <volume>25</volume> (<issue>19-20</issue>), <fpage>1341</fpage>&#x2013;<lpage>1346</lpage>. <pub-id pub-id-type="doi">10.1089/ten.TEA.2019.0208</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takebe</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sekine</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Enomura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Koike</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ogaeri</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Vascularized and functional human liver from an iPSC-derived organ bud transplant</article-title>. <source>Nature</source> <volume>499</volume> (<issue>7459</issue>), <fpage>481</fpage>&#x2013;<lpage>484</lpage>. <pub-id pub-id-type="doi">10.1038/nature12271</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Terrell</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>C. G.</given-names>
</name>
<name>
<surname>Kabandana</surname>
<given-names>G. K. M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>From cells-on-a-chip to organs-on-a-chip: scaffolding materials for 3D cell culture in microfluidics</article-title>. <source>J. Mater Chem. B</source> <volume>8</volume> (<issue>31</issue>), <fpage>6667</fpage>&#x2013;<lpage>6685</lpage>. <pub-id pub-id-type="doi">10.1039/d0tb00718h</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thelu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Catoire</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kerdine-Romer</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Immune-competent <italic>in vitro</italic> co-culture models as an approach for skin sensitisation assessment</article-title>. <source>Toxicol Vitro</source> <volume>62</volume>, <fpage>104691</fpage>. <pub-id pub-id-type="doi">10.1016/j.tiv.2019.104691</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tomas-Bort</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kieler</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Candido</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Loessner</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>3D approaches to model the tumor microenvironment of pancreatic cancer</article-title>. <source>Theranostics</source> <volume>10</volume> (<issue>11</issue>), <fpage>5074</fpage>&#x2013;<lpage>5089</lpage>. <pub-id pub-id-type="doi">10.7150/thno.42441</pub-id>
</citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turco</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Moffett</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Development of the human placenta</article-title>. <source>Development</source> <volume>146</volume> (<issue>22</issue>), <fpage>dev163428</fpage>. <pub-id pub-id-type="doi">10.1242/dev.163428</pub-id>
</citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Duinen</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Trietsch</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Joore</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Vulto</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hankemeier</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Microfluidic 3D cell culture: from tools to tissue models</article-title>. <source>Curr. Opin. Biotechnol.</source> <volume>35</volume>, <fpage>118</fpage>&#x2013;<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1016/j.copbio.2015.05.002</pub-id>
</citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Neumann</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>LeDuc</surname>
<given-names>P. R.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Tumor-on-a-chip for integrating a 3D tumor microenvironment: chemical and mechanical factors</article-title>. <source>Lab. Chip</source> <volume>20</volume> (<issue>5</issue>), <fpage>873</fpage>&#x2013;<lpage>888</lpage>. <pub-id pub-id-type="doi">10.1039/c9lc00550a</pub-id>
</citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Aji</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Organoid technology in cancer precision medicine</article-title>. <source>Cancer Lett.</source> <volume>457</volume>, <fpage>20</fpage>&#x2013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2019.04.039</pub-id>
</citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamada</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Sixt</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Mechanisms of 3D cell migration</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>20</volume> (<issue>12</issue>), <fpage>738</fpage>&#x2013;<lpage>752</lpage>. <pub-id pub-id-type="doi">10.1038/s41580-019-0172-9</pub-id>
</citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Vascularized 3D printed scaffolds for promoting bone regeneration</article-title>. <source>Biomaterials</source> <volume>190-191</volume>, <fpage>97</fpage>&#x2013;<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2018.10.033</pub-id>
</citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Carmona</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stojkova</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Garcia Huitron</surname>
<given-names>E. I.</given-names>
</name>
<name>
<surname>Goddi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bhushan</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>A 3D human adipose tissue model within a microfluidic device</article-title>. <source>Lab. Chip</source> <volume>21</volume> (<issue>2</issue>), <fpage>435</fpage>&#x2013;<lpage>446</lpage>. <pub-id pub-id-type="doi">10.1039/d0lc00981d</pub-id>
</citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoon</surname>
<given-names>J. K.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Advanced 3D cell culture platform for tissue engineering</article-title>. <source>Tissue Eng. Regen. Med.</source> <volume>20</volume> (<issue>4</issue>), <fpage>519</fpage>&#x2013;<lpage>521</lpage>. <pub-id pub-id-type="doi">10.1007/s13770-023-00562-9</pub-id>
</citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>T. S.</given-names>
</name>
<name>
<surname>Knowles</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H. W.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>3D culture technologies of cancer stem cells: promising <italic>ex vivo</italic> tumor models</article-title>. <source>J. Tissue Eng.</source> <volume>11</volume>, <fpage>2041731420933407</fpage>. <pub-id pub-id-type="doi">10.1177/2041731420933407</pub-id>
</citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chada</surname>
<given-names>N. C.</given-names>
</name>
<name>
<surname>Reinhart-King</surname>
<given-names>C. A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Microscale interrogation of 3D tissue mechanics</article-title>. <source>Front. Bioeng. Biotechnol.</source> <volume>7</volume>, <fpage>412</fpage>. <pub-id pub-id-type="doi">10.3389/fbioe.2019.00412</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>